We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-15.26%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$7.53B
AUM Growth
-$2.75B
Cap. Flow
-$1.08B
Cap. Flow %
-14.29%
Top 10 Hldgs %
12.34%
Holding
1,547
New
122
Increased
288
Reduced
505
Closed
182

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$67.4M
2
UNP icon
Union Pacific
UNP
+$58.9M
3
LLY icon
Eli Lilly
LLY
+$58.2M
4
MKC icon
McCormick & Company Non-Voting
MKC
+$55.5M
5
PLD icon
Prologis
PLD
+$44.7M

Top Sells

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$86.6M
2
DINO icon
HF Sinclair
DINO
+$82.3M
3
CAT icon
Caterpillar
CAT
+$75.6M
4
FANG icon
Diamondback Energy
FANG
+$65.1M
5
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$59.8M

Sector Composition

Rank Sector Weight
1 Financials 24.04%
2 Healthcare 13.43%
3 Consumer Discretionary 11.21%
4 Industrials 10.14%
5 Technology 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LTRX icon
1251
Lantronix
LTRX
$263M
$157K ﹤0.01%
+53,500
New +$181K
GNMX
1252
DELISTED
Aevi Genomic Medicine Inc
GNMX
$156K ﹤0.01%
223,500
– –
NOTV
1253
DELISTED
Inotiv
NOTV
$154K ﹤0.01%
121,110
-14,000
-10% -$19.6K
TRT
1254
Trio-Tech International
TRT
$109M
$152K ﹤0.01%
123,200
– –
CDTX
1255
DELISTED
Cidara Therapeutics
CDTX
$151K ﹤0.01%
3,219
-5,731
-64% -$409K
CLSD
1256
DELISTED
Clearside Biomedical
CLSD
$149K ﹤0.01%
9,280
– –
VIRC icon
1257
Virco
VIRC
$95.5M
$148K ﹤0.01%
34,400
– –
BLPH
1258
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$147K ﹤0.01%
12,200
+4,000
+49% +$58.1K
LMB icon
1259
Limbach Holdings
LMB
$593M
$146K ﹤0.01%
39,800
-14,200
-26% -$104K
SHYF
1260
DELISTED
The Shyft Group
SHYF
$145K ﹤0.01%
20,000
-158,700
-89% -$1.48M
AWRE icon
1261
Aware
AWRE
$27.8M
$143K ﹤0.01%
39,479
– –
WSR
1262
DELISTED
Whitestone REIT
WSR
$143K ﹤0.01%
+11,700
New +$159K
CARM
1263
DELISTED
Carisma Therapeutics
CARM
$142K ﹤0.01%
5,000
– –
CRWS icon
1264
Crown Crafts
CRWS
$32.1M
$141K ﹤0.01%
26,100
– –
GEG icon
1265
Great Elm Group
GEG
$67.7M
$135K ﹤0.01%
40,000
-56,219
-58% -$192K
ARL icon
1266
American Realty Investors
ARL
$242M
$134K ﹤0.01%
11,113
+13
+0.1% +$200
MFIN icon
1267
Medallion Financial
MFIN
$249M
$133K ﹤0.01%
28,300
– –
AHPI
1268
DELISTED
Allied Healthcare Products
AHPI
$133K ﹤0.01%
66,481
– –
STGW icon
1269
Stagwell
STGW
$2.16B
$132K ﹤0.01%
50,500
-134,300
-73% -$382K
ALPN
1270
DELISTED
Alpine Immune Sciences Inc
ALPN
$132K ﹤0.01%
35,750
-3,000
-8% -$14.8K
BCRH
1271
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
$128K ﹤0.01%
23,300
– –
FGH
1272
DELISTED
FG Group Holdings Inc.
FGH
$126K ﹤0.01%
109,920
– –
OPCH icon
1273
Option Care Health
OPCH
$3.55B
$125K ﹤0.01%
8,750
-39,475
-82% -$521K
FRAN
1274
DELISTED
Francesca's Holdings Corporation
FRAN
$125K ﹤0.01%
10,758
– –
MOC
1275
DELISTED
Command Security Corporation
MOC
$125K ﹤0.01%
44,600
– –
49 50
51
52 53

Similar funds

CFC
Cincinnati Financial Corp Fairfield, Ohio $4.96B AUM 18.21% 1-Year Est. Return
SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return

Bridgeway Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Bridgeway Capital Management held 1,547 positions worth $7.53B, down 27% from $10.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Bridgeway Capital Management withdrew a net $1.08B in Q4 2018, closing 182 positions and reducing 505 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $86.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Bridgeway Capital Management opened a new position in Eli Lilly worth $60.3M.

  • Bridgeway Capital Management's largest Q4 2018 buy was Eli Lilly: 521,450 shares worth $60.3M.
  • Bridgeway Capital Management added most to Merck in Q4 2018, an estimated $67.4M increase.
  • Bridgeway Capital Management's biggest Q4 2018 reduction was ON Semiconductor, cutting an estimated $54.9M.
  • Bridgeway Capital Management fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $86.6M.
  • Bridgeway Capital Management's ten largest holdings make up 12% of its $7.53B portfolio in Q4 2018.
  • Bridgeway Capital Management opened 122 new positions and closed 182 in Q4 2018.
  • Bridgeway Capital Management's portfolio value fell 27% quarter-over-quarter to $7.53B.

Based on Bridgeway Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.